Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-08
DOI
10.1007/s11060-020-03682-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading
- (2020) David N. Louis et al. BRAIN PATHOLOGY
- Quantitative characterization of tumor cell-free DNA shortening
- (2020) Juntang Guo et al. BMC GENOMICS
- Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
- (2019) Alexandra M. Miller et al. NATURE
- Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas
- (2019) Karisa C. Schreck et al. JOURNAL OF NEURO-ONCOLOGY
- cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
- (2019) David W. Ellison et al. ACTA NEUROPATHOLOGICA
- Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
- (2019) Saenz-Antoñanzas et al. Cancers
- A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient
- (2019) Yutaka Fujioka et al. NEUROPATHOLOGY
- cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant
- (2018) David N. Louis et al. ACTA NEUROPATHOLOGICA
- cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)
- (2018) David N. Louis et al. ACTA NEUROPATHOLOGICA
- TERT promoter mutation detection in cell-free tumor-derived DNA in patients withIDHwild-type glioblastomas - a pilot prospective study
- (2018) Tareq A. Juratli et al. CLINICAL CANCER RESEARCH
- Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid
- (2018) Francisco Martínez-Ricarte et al. CLINICAL CANCER RESEARCH
- Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
- (2018) Lena Gorgannezhad et al. LAB ON A CHIP
- cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
- (2018) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
- (2018) Florent Mouliere et al. EMBO Molecular Medicine
- The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid
- (2017) Laura S. Hiemcke-Jiwa et al. HEMATOLOGICAL ONCOLOGY
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
- (2017) Nobuhiro Hata et al. OncoTargets and Therapy
- Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
- (2017) Tina Y. Huang et al. Acta Neuropathologica Communications
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
- (2016) Matthew W. Snyder et al. CELL
- Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
- (2016) Elena I. Pentsova et al. JOURNAL OF CLINICAL ONCOLOGY
- Precise Detection of IDH1/2 and BRAF Hotspot Mutations in Clinical Glioma Tissues by a Differential Calculus Analysis of High-Resolution Melting Data
- (2016) Ryusuke Hatae et al. PLoS One
- Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
- (2015) David A. Solomon et al. BRAIN PATHOLOGY
- Brain Tumor Mutations Detected in Cerebral Spinal Fluid
- (2015) W. Pan et al. CLINICAL CHEMISTRY
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
- (2015) Yuxuan Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Digital PCR Modeling for Maximal Sensitivity, Dynamic Range and Measurement Precision
- (2015) Nivedita Majumdar et al. PLoS One
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- H3F3A K27M mutations in thalamic gliomas from young adult patients
- (2013) Koki Aihara et al. NEURO-ONCOLOGY
- Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma
- (2012) Xinlong Ma et al. NEURO-ONCOLOGY
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
- (2011) Benjamin J. Hindson et al. ANALYTICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started